Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients

Figure 1

Kaplan–Meier curves and log-rank test results of survival analyses of patients with node-negative advanced gastric cancer based on the clinicopathological parameters. (a) Patients with tumor size ≤5 cm or tumor size >5 cm. (b) Patients with G1, G2, or G3 differentiation. (c) Patients with non-lymphovascular invasion or lymphovascular invasion. (d) Patients with retrieved lymph nodes ≥15 or retrieved lymph nodes <15. (e) Patients with T2, T3, T4a, or T4b stage.

(a)

(b)

(c)

(d)

(e)